• Return to Headlines

Genmark Diagnost Shares Down 25.1% Since SmarTrend's Sell Call (GNMK)

By Shiri Gupta

SmarTrend identified a Downtrend for Genmark Diagnost (NASDAQ:GNMK) on October 2nd, 2018 at $6.89. In approximately 2 months, Genmark Diagnost has returned 25.05% as of today's recent price of $5.16.

Over the past year, Genmark Diagnost has traded in a range of $3.98 to $8.81 and is now at $5.12, 29% above that low. The 200-day and 50-day moving averages have moved 0.15% higher and 2.91% lower over the past week, respectively.

GenMark Diagnostics Inc. is a molecular diagnostics company focused on developing and commercializing its biomarker detection technology. The Company's system supports a broad range of molecular diagnostic tests with a compact workstation and self-contained disposable test cartridges.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Genmark Diagnost.

Log in and add Genmark Diagnost (GNMK) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights genmark diagnost

Ticker(s): GNMK